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Abstract
Peripheral glia are known to have a critical role in the initial response to axon damage and
degeneration. However, little is known about the cellular responses of non-myelinating glia
to nerve injury. In this study, we analyzed the transcriptomes of wild-type and mutant (lack-
ing peripheral glia) zebrafish larvae that were treated with metronidazole. This treatment
allowed us to conditionally and selectively ablate cranial sensory neurons whose axons are
ensheathed only by non-myelinating glia. While transcripts representing over 27,000 genes
were detected by RNAseq, only a small fraction (~1% of genes) were found to be differen-
tially expressed in response to neuronal degeneration in either line at either 2 hrs or 5 hrs of
metronidazole treatment. Analysis revealed that most expression changes (332 out of the
total of 458 differentially expressed genes) occurred over a continuous period (from 2 to 5
hrs of metronidazole exposure), with a small number of genes showing changes limited to
only the 2 hr (55 genes) or 5 hr (71 genes) time points. For genes with continuous alterations
in expression, some of the most meaningful sets of enriched categories in the wild-type line
were those involving the inflammatory TNF-alpha and IL6 signaling pathways, oxidoreduc-
tase activities and response to stress. Intriguingly, these changes were not observed in the
mutant line. Indeed, cluster analysis indicated that the effects of metronidazole treatment on
gene expression was heavily influenced by the presence or absence of glia, indicating that
the peripheral non-myelinating glia play a significant role in the transcriptional response to
sensory neuron degeneration. This is the first transcriptome study of metronidazole-induced
neuronal death in zebrafish and the response of non-myelinating glia to sensory neuron
degeneration. We believe this study provides important insight into the mechanisms by
which non-myelinating glia react to neuronal death and degeneration in sensory circuits.
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Introduction
In the peripheral nervous system, damage to and/or loss of sensory neurons can result in debili-
tating neuropathies [1–7] that often have a dramatic impact on quality of life. The cellular
mechanisms involved in the response of neurons and glia to such pathological insults are
poorly understood. Identification of the genes involved in the regulation and dysregulation of
these pathways could offer the promise of new therapeutic approaches to treating these
disorders.
Investigations into the pathophysiology of neuronal damage/death typically have utilized
experimental paradigms involving non-selective damage to peripheral nerves; e.g., constricting,
crushing or cutting nerves [8–10] or using non-targeted pharmacological agents [11, 12]. Such
studies have shown that peripheral glia play critical roles in both the degenerative and regener-
ative processes that are involved in the responses to peripheral nerve damage [13–15]. Most
efforts have focused primarily on myelinating Schwann cells [15–18], with the result that very
little is known regarding how the non-myelinating glia that ensheath axons and neuronal
somas respond to nerve damage. This is a significant knowledge gap given that approximately
80% of cutaneous nerve fibers are unmyelinated [19, 20], that they transduce such important
modalities as itch, pain, temperature and mechanosensation [21–25], and that they are affected
in many prevalent peripheral neuropathies [26].
Previous work from this lab has shown that the peripheral sensory circuits in the head are
formed in zebrafish by 4 dpf [27]. At this stage, the neurons in the cranial ganglia are encapsu-
lated by satellite glia and their axons are ensheathed by peripheral glia. Unlike the lateral line
nerves of the head and trunk, the trigeminal and epibranchial circuits are unmyelinated at 4
dpf and remain so until at least 10 dpf [28]. Thus the ensheathing glia of these circuits are non-
myelinating Schwann cells. In a recent report, we described a zebrafish line that allows for the
selective ablation of these unmyelinated cranial nerves using the metronidazole (MET)-nsfB
cell-death system [29]. Upon exposure to MET, the cranial neurons selectively expressing the
nsfB transgene quickly died, with the affected cell bodies and axons degenerating over the
course of 18 hours of treatment. This model therefore offers an opportunity to investigate the
response of non-myelinating glial to nerve degeneration without the confounding contribu-
tions of myelinating Schwann cells. Of particular relevance to the current study is the fact that
these neurons, and their unmyelinated axons, are restricted to the head.
The organismal response to loss of the affected sensory neurons and their axons was com-
posed of several phases. The first phase, occurring in the first 5 hours of treatment, consisted of
increased cell death followed closely by the beginnings of axonal degeneration. The second
phase, occurring between 5–18 hours of treatment, comprised phagocytosis of the cell body/
axonal debris and recruitment of macrophages to the areas of degeneration. Further analysis
using foxd3zd10 mutants, which lack peripheral glia, demonstrated that both phagocytosis of
axonal/neuronal debris and recruitment of immune cells were dependent on the presence of
the non-myelinating glia ensheathing the neuronal somas and axons [29].
In this report, we utilized RNA-seq to identify genes that were differentially expressed in the
larval head during the process of sensory neuron ablation and axon degeneration. Transcrip-
tome analysis revealed that MET-induced toxicity affected only a small subset of genes (a total
of 458, which is<1% of the total number found to be expressed in the head at this stage). Sig-
nificant changes in gene expression reflected alterations in a select number of cellular path-
ways: e.g., membrane transport, anti-inflammatory pathways, oxidative stress, metabolism and
cytokine signaling. Analyses were also carried out using RNA isolated from mutant larvae
(foxd3zd10 nulls) that lack all peripheral glia [29–31]. In those experiments, no significant effect
was seen on pathways involved in cytokine signaling, response to stress and oxidoreductase
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activities. Overall, the information regarding differential gene expression in these conditions
provide a basis for further investigation into the cellular processes that underlie pathophysio-
logical responses of neurons and glia to sensory nerve damage.
Materials and Methods
Ethics Statement
All experiments were carried out in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. The Saint Louis University Animal Care Commit-
tee approved the procedures used (protocol # 1619) and all efforts were made to minimize the
number of animals used and their suffering.
Maintenance of fish and fish strains
All animal husbandry was carried out as described by Westerfield [32], and staging was carried
out using the criteria of Kimmel et al. [33]. For some experiments, reduction of pigmentation
of embryos/larvae was achieved by growing embryos in fish water containing phenylthiourea
(PTU) at a concentration of 0.0015%. The following strains were used: Tg(p2rx3.2(-4.0):
gal4vp16);Tg(UAS:nsfB-mcherry), Tg(p2rx3.2(-4.0):gal4vp16);Tg(UAS:nsfB-mcherry):csfr1aj4e1
and Tg(p2rx3.2(-4.0):gal4vp16);Tg(UAS:nsfB-mcherry):foxd3zd10 [29], and Tg(p2rx3.2(-4.0):
gal4vp16);Tg(kaede) [34].
Metronidazole treatment
Larvae at 4dpf were treated with metronidazole (Sigma, St. Louis, MO) at a final concentration
of 10 mM in fish water for either 2 or 5 hours. Control fish were treated with fish water alone.
Verification of neuron ablation was carried out using epifluorescent imaging as described in [29].
RNA sequencing and bioinformatic analyses
Heads of 4 dpf larvae exposed to 10 mMMET for either 0, 2 or 5 hours were dissected using a
small scalpel (Katena Products Inc.), with 8 heads pooled per sample. Each sample was then
homogenized in 250 μL of TRIzol (Life Technologies), and total RNA extracted. The RNA sam-
ples were then treated with DNase and column purified using a Qiagen RNEasy mini kit (Qia-
gen, Inc.). Biological triplicates were prepared for each condition. At this point, the total RNA
samples were supplied to the Genome Technology Access Center at Washington University in
St. Louis for library construction and high-throughput sequencing. RNA purity and integrity
was determined using an Agilent Bioanalyzer 2100, and only those samples having a RIN> 8.7
were used. For library construction, 1 μg total RNA was used for each wild-type replicate and
0.35 μg for the mutant replicates. The total RNA samples were depleted of rRNA using the
Ribo-Zero protocol (Epicentre). cDNA was synthesized, blunt ended, an A base added to the 3’
ends and Illumina sequencing adapters ligated using a proprietary protocol with enzymes from
Enzymatics (Qiagen). cDNA fragments were then amplified for 12 cycles using primers incor-
porating unique index tags and multiplexed sequencing was performed using an Illumina
HiSeq2500 platform (single end, 50 bp reads).
RNA-seq reads were aligned to the Danio rerio Zv9 assembly from Ensembl with STAR
[35] version 2.0.4b. Gene counts were derived from the number of uniquely aligned unambigu-
ous reads by Subread:featureCount [36], version 1.4.5. Transcript counts were produced by
Sailfish [37], version 0.6.3. Sequencing performance was assessed for total number of aligned
reads, total number of uniquely aligned reads, genes and transcripts detected, ribosomal frac-
tion, known junction saturation and read distribution over known gene models with RSeQC
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[38] version 2.3. All gene-level and transcript counts were then imported into the R/Bioconduc-
tor package EdgeR [39] and TMM normalized to adjust for differences in library size. Genes or
transcripts not expressed in any sample were excluded from further analysis. Performance of the
samples was assessed with a Spearman Correlation Matrix (S1 Fig). The data generated in this
study has been deposited in the National Center for Biotechnology Information Gene Expression
Omnibus (GEO) database (accession number GSE 72682). Generalized linear models with robust
dispersion estimates were created to test for gene/transcript level differential expression. The fit
of the trended and tagwise dispersion estimates were then plotted to confirm proper fit of the
observed mean to variance relationship where the tagwise dispersions are equivalent to the bio-
logical coefficients of variation of each gene. Differentially expressed genes and transcripts were
then filtered for those having fold-changes (FC)> 1.2 together with false-discovery rate (FDR)
adjusted p-values less than or equal to 0.05. R/Bioconductor package “gplots” was used to gener-
ate the heatmaps. The differentially expressed zebrafish genes in each condition were transferred
to their human orthologs by using the PANTHER classification system (http://pantherdb.org/
genes/index.jsp), then GO enrichment analysis was performed in ToppGene suite [40], with the
p-value cut-off< 0.05 (corrected using the Benjamini and Hochberg (B&H) procedure).
A primary consideration in performing GO analysis was how to organize the identified DEGs
into the requisite sets. Given that a relatively small population of cells in the head would be
expected to be directly affected by MET treatment (peripheral sensory neurons, the peripheral
glia that ensheath them, and a small number of 3.2:NTR+ retinal cells), there was some concern
that information might be lost if the pool of genes analyzed were chosen using too stringent of
cutoffs. Also, since the exposure to MET was continuous over the 5 hrs, we also wanted an
approach that would treat the data as dynamic rather than static. And most importantly, it was
critical to have confidence in the analyses. Therefore, the following analytic strategy was used.
First, a master pool which contained only the genes that met stringent statistical cutoffs (in our
case, B&H derived FDR<0.05 and FC>1.2 or<-1.2) at either 2 hrs, 5 hrs, or at both time points
was formed. Next, the FC values for each of the genes in the pool which met both cutoff values at
one time point only were evaluated as a means to identify DEGs that were significant at one time
point but whose expression was trending either up (FC> 1.2) or down (FC<1/1.2) at the time at
which their FDR>0.05 (non-significant). Based on those two sets of criteria, it was possible to
segregate the DEGs into one of three categories- 1) early response: contains DEGs which met the
FDR and FC cutoffs at 2 hrs but not at 5 hrs, 2) continuous response: contains the sets of DEGs
that met the FDR and FC criteria at both time points plus those that met the FDR and FC cutoffs
at one time point but only the FC at the second time point, and 3) late response: those DEGs
which met the FC and FDR criteria at 5 hrs but not at 2 hrs.
Quantitative PCR
Total RNA was extracted from different experimental animals than those used for the tran-
scriptome analysis using the protocol detailed above. Oligo-dT primed cDNA was then synthe-
sized using a Superscript III first-strand synthesis kit (Life Technologies, INC), and qPCR
carried out using validated prime sets obtained from SA Bioscience (Qiagen, Inc). For the
qPCR, 1 μL of cDNA was used in a 10 μL SYBR green reaction mix. PCR and post-reaction
analysis was carried out using a StudioQuant 6 PCR machine (Life Technologies, Inc).
Analysis of Neurogenesis
Previous work by others have shown that the photoconvertible protein kaede can be used as a
tool in neuronal birthdating [41]. Kaede is a green fluorescent protein that is converted into a
stable red-fluorescent fragment after exposure to UV light. Given that the cranial sensory
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ganglia consist of tightly-packed clusters of neurons, we chose an approach that would allow us
to obtain labeling of only a small number of neurons in each ganglion, so that we could reliably
quantitate labeled cell bodies. To accomplish this, we obtained variegated expression of kaede
in the epibranchial neurons using a binary expression system (p2rx3.2−4.0:gal4VP16;UAS:
kaede) [34]. On the first day (3, 4, 5 or 7 dpf), photoconversion was carried out on live
embryos/larvae that had been anesthetized with tricaine (0.01%). Conversion was performed
using a 20x water immersion objective mounted on an Olympus FV-1000 MPE confocal
microscope, with the region of interest (ROI) being the area containing the epibranchial gan-
glia. Before photoconversion was performed, a scan was done to verify that there was no pre-
existing red-fluorescence within the ROI. Next, while imaging the target area in both the red
and green channels, the 405nm laser was applied at a power of 0.5% or 1% for up to 1 minute,
resulting in nearly all green fluorescence disappearing while robust red fluorescence appeared
in every kaede+ neuron. The embryos/larvae were then washed 3x with fish water and returned
to the fish facility. After 24 hours, the photoconverted embryos/larvae were then imaged again
in both the green and red channels, with z-stacks being obtained. All z-planes were collapsed
into maximal intensity projections using either Olympus Fluoview or NIH ImageJ software.
Numbers of green+/red- and green+/red+ neurons were counted in each z-stack, with 4–11
embryos/larvae examined per time point studied. Final brightness and/or contrast values of
images were adjusted in Adobe Photoshop CS4.
Results and Discussion
Our working hypothesis is that alterations in gene expression underlie the morphological
responses that are seen with metronidazole (MET)-induced cranial neuron ablation and axon
degeneration in this transgenic line. To test this, we analyzed the transcriptome of 4 dpf zebra-
fish larval heads after two and five hours of MET treatment. Two hours was chosen as our pre-
vious work demonstrated that at this point sensory neurons had begun to die and the most
distal aspect of nsfB-mCherry+ axons were beginning to show structural alterations at both the
light and electron microscopic levels. Five hours of MET exposure was chosen as by this time
additional neurons were dying, phagocytosis of the sensory axons along their entire lengths
had begun and recruitment of immune cells was initiated.
We chose to use the larval head as our RNA source for several reasons: first, there are no
currently available zebrafish lines that allow for neuron or peripheral glia-specific transcrip-
tome analysis, and second, at this stage the projections of the affected cranial sensory neurons
are almost entirely restricted to the head. Therefore, using larval heads would ensure that we
would capture any gene expression changes occurring in the targeted neurons, their ensheath-
ing glia and, potentially, any cells undergoing sensory denervation as well. Sequencing to a
depth greater than 30 million reads was carried out to ensure good representation of transcrip-
tional changes that could occur in such a complex tissue (containing cells from dermis, muscle,
nerves, ganglia, cartilage, mesenchyme, etc).
RNA was isolated from triplicate biological samples from 4 dpf 3.2:NTR larvae treated with
MET for either 0, 2 or 5 hours and subjected to RNA-seq. The transcriptome at two hours was
sequenced to a depth of ~ 35 million reads/replicate, with ~94% of reads being uniquely
mapped to the genome. This resulted in ~21 million gene counts per sample, which translates
to an average of 27,098 genes detected per biological replicate. As the Zv9 genome assembly at
Ensembl [42] predicts a total of 33,737 genes, our sequencing revealed that at this age the tis-
sues in the head of the larvae expressed at least 81% of all predicted genes found in the zebrafish
genome. Samples for the 5 hour time point were also sequenced to a depth of ~ 35 million
reads. 95% of those mapped uniquely to the genome and gene counts revealed a total of 27,169
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genes were detected. Since both sets of sequences yield equivalent depths of reads and coverage,
analyses of the data was expected to provide reliable results. A detailed summary of the
sequencing results is given in S1 Table.
Differential Gene Expression
When the 2 hour transcriptome was compared to that of untreated controls, a total of 273
unique differentially expressed genes (DEGs) were detected (S2 Table). Of these, 179 were up-
regulated and 94 down-regulated. The 10 transcripts in each group showing the greatest fold-
changes are shown in Table 1. When RNA biotype was considered, there were 261 protein-cod-
ing RNAs, four long non-coding RNAs and eight processed transcripts (originating from cod-
ing genes, they are spliced but contain no open reading frame).
Analysis of the transcriptome at 5 hours of MET treatment, compared to that of controls,
revealed a total of 299 unique DEGs (S3 Table). Of these, 236 were up-regulated and 63 down-
regulated. The 10 transcripts in each group showing the greatest fold-change are also shown in
Table 2. When RNA biotype was considered, there were 284 protein coding RNAs, four long
non-coding RNAs, nine processed transcripts (spliced but containing no open reading frame),
one miRNA and one snoRNA.
For both time points, approximately 25–30% of affected genes could not be unambiguously
identified. This was most probably due to either low sequence homologies with orthologous
genes in other species, or that they represent unidentified teleost-specific genes. Those genes
were not included in our analyses, as future studies will be needed in order to determine their
identity and function.
Given that different processes were detectable by imaging at the two time periods examined,
we expected the two DEGs panels would not be identical. Indeed, only 114 transcripts were
Table 1. Transcripts showing greatest fold change at 2 hr met treatment.
GENE NAME DESCRIPTION Log FC
UP-REGULATED
CR788316.1 Uncharacterized protein, similar to verrucotoxin beta subunit 8.32766
CR788316.2 Uncharacterized protein, similar to neoverrucotoxin beta subunit 7.7638
si:ch73-313h21.1 processed transcript 4.99491
novel gene 100034660 Uncharacterized protein, endopeptidase S1 family 4.79187
asb11 ankyrin repeat and SOCS box-containing 11 3.31716
slc2a9l1 facilitated glucose transporter 2.26845
trim35-27 tripartite motif containing 35–27 1.86052
cx44.2 connexin 44.2 1.8152
tat tyrosine aminotransferase 1.80159
cyp24a1 cytochrome P450, family 24, subfamily A, polypeptide 1 1.77717
DOWN-REGULATED
si:ch1073-133p4.2 lincRNA -4.87545
BX470200.1 Uncharacterized protein -4.74224
ENSDARG00000074250 homeobox-containing unknown protein -4.55278
gck glucokinase (hexokinase 4, maturity onset diabetes of the young 2) -3.63392
CR846087.1 Uncharacterized protein -2.89839
nr0b2b nuclear receptor subfamily 0, group B, member 2b -2.85148
si:dkey-220o5.5 actin ﬁlament associated protein 1-like 2 -2.82413
zgc:172053 zgc:172053 -2.76296
si:dkey-25e11.13 processed transcript -2.6941
si:dkey-31b16.11 processed transcript -2.504
doi:10.1371/journal.pone.0148726.t001
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shared between them, indicating that 159 genes present in the 2 hr DEGs pool were no longer
different from control by 5 hours of treatment, and conversely, that 185 genes in the 5 hour
pool had only become significantly altered after 2 hours of treatment. Of the 114 DEGs genes
that were shared at 2 and 5 hours, 100 were up-regulated (vs. control) at both time points, with
the other 14 DEGs down-regulated at both times.
The finding that only 1% of all genes detected in the samples showed differential expression
at either time point revealed how discrete the effects of MET exposure were in the larval head.
Also, the substantial differences in the DEG detected at either 2 or 5 hrs MET treatment indi-
cate a dynamic change in gene expression that parallels the progressive organismal responses
to MET-induced neuronal degeneration/death.
Validation of results by quantitative PCR
To validate the expression profiles from the transcriptome analysis, we used qPCR to test the
expression levels of targets that are differentially expressed at 2 hours only (ifit2, cyp51, lpin1 and
trim35-30), at 5 hours only (grk5, gsr, il6st, junbb and tnfrsf1a) and at both 2 and 5 hours (cdca7a,
nr02b2, cyp24a1, fosl1a, and tp53inp1). Both up- and down-regulated genes are represented in
these lists. As illustrated in Fig 1, the fold-change determined by qPCR for these genes showed
strong and significant correlations to the values ascertained using RNAseq (for 2 hrs, r2 = 0.85,
p<0.001; for 5 hrs, r2 = 0.83, p<0.001), findings which confirm the RNAseq results.
Gene enrichment analysis of differentially expressed genes at 2 and 5
hours of MET-treatment
Having identified genes showing differential expression at the two time points, our next step
was to use gene enrichment analysis to gain insight into the biological, cellular and molecular
Table 2. Transcripts showing greatest fold change at 5 hr MET treatment.
GENE NAME DESCRIPTION Log FC
UP-REGULATED
si:ch211-277g23.4 processed transcript 3.65999
si:dkey-29l4.4 lincRNA 3.25823
U3 Small nucleolar RNA U3 2.82427
slc2a9l1 facilitated glucose transporter 2.77719
CABZ01055869.1 uncharacterized protein, desmoglein 2-like 2.46025
cx44.2 connexin 44.2 2.36785
fosl1a FOS-like antigen 1a 1.99903
si:ch211-120c15.3 uncharacterized protein, zinc-ﬁnger-like 1.98911
trim35-27 tripartite motif containing 35–27 1.91738
capn1 calpain 1 1.87402
DOWN-REGULATED
ENSDARG00000074250 uncharacterized homeobox-containing protein -4.51379
CABZ01034082.1 uncharacterized protein, zinc-ﬁnger -3.72908
gck glucokinase (hexokinase 4, maturity onset diabetes of the young 2) -3.70692
si:dkey-228g21.5 processed transcript -3.26187
CU207281.2 5-hydroxytryptamine 3A-like receptor -2.63325
si:ch211-135n15.2 uncharacterized protein -2.00013
zgc:174917 phytanoyl-coA dioxygenase domain-containing protein 1-like -1.83274
zgc:111976 RNA polymerase II subunit 1-like -1.79444
cyp2aa9 cytochrome P450, family 2, subfamily AA, polypeptide 9 -1.71989
si:ch73-334d15.4 potassium voltage-gated channel, Shaw-related subfamily, member 4-like (kcnc4-like) -1.68789
doi:10.1371/journal.pone.0148726.t002
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processes potentially involved in the observed morphological responses. This was performed
using GO (Gene Ontology) databases using the paradigm described in the Methods section.
We were able to assign the 458 DEG (Fig 2A) into either the early response, continuous
response or late response groups (Fig 2B).
The 55 DEG that were binned into the early response category could be further divided into
38 genes that showed up-regulation and 17 that were down-regulated. Due to this small num-
ber of DEGs, GO analysis resulted in only a few categories showing significant enrichment, and
then only for the set of up-regulated DEGs; e.g. those involved in inflammation (pnpla3 and
pl2g15), membrane transport (abcc5, slc7a2, slc12a7 and slc38a4) and responses to cyclic nucle-
otides (pde3a and hcn4) (Fig 3 and S4 Table).
With respect to DEGs that fell into the continuous category, 217 genes were found to show
increased transcript numbers. The GO categories showing enrichment for these up-regulated
Fig 1. qPCR validation of representative DEGs at 2 and 5 hrs MET-treatment. Panel A: Plot of nine
genes, found to be significantly affected after 2 hr of MET, showing RNAseq derived fold change (FC) (x-axis)
vs. qPCR derived FC (ΔΔCt) (y-axis). Panel B: Plot of ten genes, found to be significantly affected after 5 hr of
MET, showing RNAseq derived FC (x-axis) vs. qPCR derived FC (y-axis). Each point is the mean derived
from three unique replicate biological samples. Linear regression (R2) values are shown inside each plot
(p<0.001 for each panel).
doi:10.1371/journal.pone.0148726.g001
Gene Expression Changes during Sensory Neuron Degeneration
PLOS ONE | DOI:10.1371/journal.pone.0148726 February 10, 2016 8 / 21
genes (Fig 4 and S5 Table) included many for membrane transporter (37 DEGs) and metabolic
activities (41 DEGs), processes that would be expected to be altered in the sensory neurons
undergoing cell degeneration, as well as in supportive responses by the ensheathing glial cells.
Additional categories with significant enrichment included oxidoreductase and oxidation-
reduction activities, and the mitochondrion was scored as an affected cellular component.
Given that metabolism of MET results in highly reactive cytotoxins [43], it is not unexpected
that genes relevant to oxidative stress and mitochondrial function might be represented in the
panel of DEGs. Indeed, 16 DEGs were found in the GO category for oxidoreductase activity
(abcc4, cyp24a1, cyp51a1,me1, pgd, dio3, hsd11b2, bbox1, hsdl2, tp53i3, tdo2, pir, gsr, loxl2,
prdx1 and hsd17b12) and 26 DEG mapped to the mitochondrion (pdk2, pdk4, cyp24a1,
slc25a25,me1, lpin1, slc25a43, ucp2, ucp3, agxt, slc25a38, bbox1, slc25a23, tat, hsdl2, sgk1,
Fig 2. Methodological approach to analysis of DEGs identified during MET-induced sensory neuron
ablation. Panel A: Venn diagram of up- and down-regulated DEGs present at 2 hrs (green) and 5 hrs
(magenta) of MET exposure. The numbers of unique DEGs present either at one time point or found at both
times are shown inside the circles. Panel B: Table listing the criteria for inclusion of genes shown in Panel A
into one of three categories: early response, continuous response or late response. FDR = false-discovery
rate (determined using Benjamini-Hochberg procedure); FC = fold-change.
doi:10.1371/journal.pone.0148726.g002
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Fig 3. Analysis of genes found up-regulated only at 2 hrs of MET-treatment. Panel A: Plot of gene expression averaged from 3 biological replicates for
those DEG found to only be up-regulated at 2 hrs of treatment. Panel B: Representative GO categories enriched for the up-regulated genes are shown with
length of bar corresponding to degree of significance (longer bars = greater significance), p-values determined by Benjamini-Hochberg procedure.
doi:10.1371/journal.pone.0148726.g003
Fig 4. Analysis of DEGs present in the continuous expression group. Panel A: Plot of gene expression
averaged from 3 biological replicates for those DEGs found to be up-regulated (red) or down-regulated (blue)
between 2 and 5 hrs of MET treatment. Expression values beyond the means for each group at each time
point are shown as single points either above or below the error bars. Panel B: Representative GO categories
enriched for the up-regulated genes are shown. Panel C: Representative GO categories showing enrichment
for the down-regulated genes are shown. For both Panels B and C, length of bar corresponds to degree of
significance (longer bars = greater significance), p-values determined by Benjamini-Hochberg procedure.
doi:10.1371/journal.pone.0148726.g004
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slc25a33, slmo2, abcb6, abcf2, cpt1b, gsr, arg2, gstp1, prdx1 and abcc12). Notably, and consistent
with the up-regulation of genes associated with mitochondrial function, the gene with one of
the largest reductions in expression at both 2hr (FC = -13.2, FDR = 7.18e-5) and 5hr (FC =
-13.1, FDR = 2.2e-6) was gck: this finding is consistent with other reports that describe substan-
tial down-regulation of gck expression in models of mitochondrial dysfunction [44, 45].
The remaining 115 DEGs in the continuous category belonged to the down-regulated subcate-
gory. Here, fewer GO categories were found to contain significant enrichment; however, one such
category contained phospholipase A2 inhibitors (anxa1 and anxa2). A reduction in PLA2 inhibi-
tion would be consistent with the hypothesis that MET-induced cell death results in an inflamma-
tory state. Another set of categories was involved in DNA replication/mitosis and chromatin (irf1,
pogz,med1, esco2, ppp1r10, hist1h1d, hist1h1a, dnmt3b, hellse2f2,mcm10, skp2, dhfr, cdc6 and
cdk2) (Fig 4 and S6 Table). These results were somewhat surprising given that the ablated sensory
neurons are post-mitotic. There are two possibilities that could contribute to such findings- the
first is that these DEG reflect changes occurring in the target cells (e.g., taste buds, skin, chemo-
sensory cells, etc. [46–50]) of the affected neurons due to contact with degenerating axons, while a
second is that mitotically active neuronal progenitors expressing nsfB are being ablated. As previ-
ous work from this lab suggested that the latter might be occurring [27, 51], additional experi-
ments testing this possibility were performed and are discussed in the following section.
Finally, GO analysis of the late response DEGs (a total of 71 genes) revealed that as the lar-
vae were exposed to MET for longer times (5 hrs), new sets of DEGs were identified that revealed
enrichment in new categories such as those involved in metabolism (cers2,mgst1, gclm, sgpl1, gls,
papss2, sqrdl, cyp46a1, g6pd, ptgs2, ggt1 and slc5a1), transcriptional regulation (cebpb, cebpd,
bach1, epas1, cers2, junb,maff and stat3), glutathione metabolism (mgst1, gclm, g6pd and ggt1) and
IL-6/TNF signaling pathways (sele, cebpb, cebpd, stat3, junb, creb3l3, tnfrsf1a and il6st) (Fig 5 and
S7 Table). All of these new categories are consistent with the hypothesis that as neuronal death
and axon degeneration increases with time in MET, gene networks involved in inflammatory pro-
cesses such as glutathione metabolism and cytokine signaling become activated. The few categories
Fig 5. Analysis of genes found up- or down-regulated only at 5 hrs of MET-treatment. Panel A: Plot of
gene expression averaged from 3 biological replicates for those DEGs found to only be differentially
regulated at 5 hrs of treatment. Panel B: Representative GO categories enriched for the up-regulated genes
are shown. Panel C: Representative GO categories showing enrichment for the down-regulated genes are
shown. For both Panels B and C, length of bar corresponds to degree of significance (longer bars = greater
significance), p-values determined by Benjamini-Hochberg procedure.
doi:10.1371/journal.pone.0148726.g005
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found for the down-regulated DEGs (Fig 5 and S8 Table) were primarily concerned with mRNA
processing (srsf6 and srsf1) and phototransduction (sag and gnb5); this latter category represents
the fact that the small numbers of retinal cells expressing the 3.2:NTR transgene (data not shown)
are ablated after prolonged exposure to MET.
Subcategory of DEGs reflect neurogenesis
As previously described, there were a number of transcripts encoding proteins involved in cell
cycle (cdk2, dtl, E2F2, E2F3, skp2, and slbp) and DNA replication (cdc6, chtf8, dhfr, esco2, lig1
and mcm10) in the continuous response category that exhibited a FC> -1.2. Earlier work from
this lab demonstrated the p2rx3.2 promoter fragment used also drives transgene expression in
the progenitors of the epibranchial neurons [27]. Thus, the decreased numbers of transcripts
for genes involved in mitosis and DNA replication might be reflective of the loss of these NTR-
expressing progenitors. If this were the case, then neurogenesis of the ganglionic neurons
would need to be occurring before and during the time of MET exposure. To test this possibil-
ity, we exploited the photoconvertible fluorescent reporter kaede, which has been used by oth-
ers as a tool for birthdating peripheral neurons [41]. Neurogenesis was investigated in the
larvae between 3–8 dpf, when the bulk of the ganglia form and complete their circuitry, and
which brackets the time frame of our MET experiments [27]. Our approach allowed us to dis-
cern which neurons were present before photoconversion (contain both red and green fluores-
cence) versus neurons born since photoconversion (green alone). One such conversion
experiment is shown in Fig 6. Fig 6A and 6A’ illustrate the ability to completely convert the
green form of kaede in sensory neurons into the red form. Fig 6B–6B” show that 20 hrs later,
newly biosynthesized green kaede was detectable in both old and nascent neurons in the same
larva. Conversion was performed on four to eleven individual larvae for each time point, with
the total number of neurons counted post-conversion ranging from 376 to 870. The results
from these experiments are summarized in Fig 6C, which shows that new neurons were added
to the cranial ganglia throughout the 3–6 dpf time period. The data showed that production of
new sensory neurons was highest during the 3–4 dpf period, and decreased steadily thereafter,
although small numbers of new neurons were still being added even at the 7–8 dpf period. Of
particular relevance was that roughly 30% of existing neurons at 5 dpf were born during the
time frame of the MET experiments (i.e., between 4–5 dpf). Therefore, the observed decreases
in transcripts related to cell cycle and DNA replication genes could be at least partially
explained by the MET-induced cell death of neuronal progenitors.
Absence of peripheral glia alters the gene expression landscape in
larvae undergoing sensory neuron degeneration
Two of the most obvious morphological changes seen in larvae after 5 hrs of MET treatment,
the formation of mCherry+ puncta in the cranial nerves and the recruitment of macrophages to
the degenerating unmyelinated sensory axons/neurons, were shown to be dependent upon the
presence of peripheral glia [29]. Previous work has shown that in response to nerve injury,
myelinating Schwann cells undergo a conversion from a supporting cell to a repair cell, which
begins the processes of phagocytosis and inflammation [15]. This dedifferentiation/transdiffer-
entiation is mediated by altered gene expression [14, 52]. We postulate a similar process occurs
in non-myelinating glia and could account for the responses seen in our model of unmyelin-
ated nerve injury. We propose that comparison of gene expression after 5 hrs of MET treat-
ment in the wild-type larvae to that in treated mutant larvae would identify the gene pathways
used by non-myelinating glia. To test this possibility, we carried out the next set of experiments
using the 3.2:NTR;foxd3zd10 line, in which the mutants lack peripheral glia [27, 30, 31].
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cDNA libraries were prepared as previously described and subjected to Illumina sequencing
to an average depth of 31 million reads for control and 35 million reads for treated replicates.
The percentage of reads mapped, the number of genes identified and the percentage of reads
Fig 6. Epibranchial neurogenesis is occurring during timeframe of MET treatment. Panels A and A’ respectively, show the green and red (magenta)
images of epibranchial neurons in a 76 hpf p2rx3.2−4.0:gal4VP16;UAS:kaede larva just after exposure to a 405nm laser: note that all kaede has been
converted to red fluorescence. Panels B, B’ and B” show the same embryo 20 hours later in the green, magenta and combined channels, respectively. Only
newly born neurons show green fluorescence alone (some of these neurons are indicated by the arrows in B”), whereas previously existing neurons contain
both photoconverted (magenta) and newly-synthesized (green) kaede. Scale bars in A’,B = 100 μm. Panel C represents the percentage of labeled neurons
(total numbers counted are shown at the tops of the bars), 24 hours after photoconversion at the indicated stage, that were either green+/red- (newly born) or
green+/red+ (pre-existing).
doi:10.1371/journal.pone.0148726.g006
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corresponding to ribosomal RNAs were similar to those obtained with the wild-type larvae
analyzed previously (S9 Table).
Bioinformatic analyses revealed a total of 529 unique DEGs in the 3.2:ntr;foxd3-/- larvae
treated for 5 hrs with MET when compared to non-treated mutants (S10 Table). Of these, 292
were up-regulated and 237 were down-regulated DEG (FDR<0.05 and FC>1.2 / -1.2). The
RNA biotypes were found to be primarily protein coding (503), with small numbers of other
categories present: lincRNA (9), processed transcripts (8), unprocessed (3), antisense (2), mis-
cellaneous (2), mitochondrial rRNA (1) and snoRNA (1).
Comparison of the DEGs sets from the wild-type and mutant 5 hr treatments revealed that
181 DEGs were expressed in the wild-type only and 411 DEGs in the mutant only. Given that
the mutants lack peripheral glia, it is expected that the DEGs unique to the wild-type larvae
contain genes involved in the glial responses to nerve damage. We used GO analysis to identify
cellular processes altered in each condition in order to elucidate mechanisms that were glial
dependent. A first step was to confine the pools of DEGs used for analysis to those with the
least potential for false negatives (arising from biological variability across replicates that
results in FDR values that fall short of the<0.05 cutoff). Therefore, DEGs chosen for analysis
were limited to those that met both statistical cutoffs in one condition and did not reach the FC
cutoff in the other condition: e.g., for the wild-type only up-regulated DEGs analysis, we
included only those wild-type genes that met both statistical cutoffs and did not exhibit a FC
>1.2 in the mutant RNA seq results. Using these criteria, 105 DEGs from the wild-type only
pool (73 up-regulated and 32 down-regulated) and 244 DEGs from the mutant only pool (101
up-regulated and 143 down-regulated) were selected and used for analysis. Cluster analysis of
the two DEGs pools showed that distinct and non-overlapping sets of genes were up-regulated
(Fig 7A) or down-regulated (Fig 8A), indicating that the effects of MET treatment on gene
Fig 7. Comparison of foxd3mutant and wild-type up-regulated DEGs found after 5 hrs of MET treatment. Panel A is a hierarchical clustering heatmap
showing DEG (FDR<0.05 and FC > 1.2) found in each biological triplicate from either the wild-type or mutant transcriptomes. Gene expression fold-changes
to respective controls (log2 ratios) are color-coded (red up-regulated and green down-regulated) Panel B: Representative GO categories enriched for the up-
regulated genes found in the mutant; Panel C: representative GO categories enriched for the up-regulated genes found in the wild-type transcriptome. Length
of bar corresponds to degree of significance (longer bars = greater significance), p-values determined by Benjamini-Hochberg procedure.
doi:10.1371/journal.pone.0148726.g007
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expression was heavily influenced by the presence or absence of glia. When GO analysis was
performed, the mutant pool showed significant enrichment in only a small number of pro-
cesses for up-regulated genes, such as transcription factor and chromatin binding (foxo1, hif1a,
etv4, rest, clock, hif1a, rnf25,med, klf1, loxl2, hist1h1d and tp53bp2) (Fig 7A and 7B and S12
Table), while down-regulated genes fell into categories involving oxidation-reduction (cyp3a5,
cox4i1, cyp51a1, tp53i3, hsd11b1l, ptgs2,msmo1, sc5d, dhfr, tm7sf2, dio1, haao, aldh2 and
cyb5r2), sterol biosynthesis (cyp51a1, hmgcs1,msmo1, sc5d, fdps, ebp, tm7sf2, lss and cyb5r2)
and alternative complement activation pathways (cfb, cfd and c3) (Fig 8A and 8B, and S14
Table). This was the reverse of what was seen with the wild-type pool. Here, only a small num-
ber of categories were found to be enriched in down-regulated DEGs, e.g., those involving
mRNA splicing (hnrnpa0, srsf1, srsf6 and hnrnpa1) (Fig 8C and S13 Table). In contrast, the up-
regulated DEGs showed enrichment in multiple categories (Fig 7C and S11 Table), many of
which are expected to be altered in supportive cells (i.e., peripheral glia) as they respond to
cytotoxic insults to the cells they assist (neurons): e.g., oxidoreductase activity (msmo1, sc5d,
cyp51a1, bbox1 and cyp46a1) and metabolism/response to stress (ipc,msmo1, sc5d, sgpl1, agt,
ebp, cyp51a1, abcb11, lss, hmgcs1, cyp46a1, ggt1, cebpb, hist2h2be, hist1h4l, fos, epas1 and stat3).
Of particular interest are the sets of genes implicated in inflammatory responses: response to
wounding (sele, cebpb, fos, agt, cd40lg, c3, atp1b1, f5, il6st, ggt1 and stat3), IL6-mediated signal-
ing (junb, cebpb, fos, il6st, stat3 and tnfrsf1a) and TNF signaling (sele, junb, cebpb, fos and
tnfrsf1a). The up-regulation of these genes in the wild-type only pool of DEGs is in keeping
with the finding that inflammatory responses such as debris clearance and macrophage recruit-
ment were not seen in the mutant larvae, and strongly suggest that these processes are being
mediated by the peripheral glia.
Fig 8. Comparison of foxd3mutant and wild-type down-regulated DEG found after 5 hrs of MET treatment. Panel A is a hierarchical clustering
heatmap showing DEG (FDR<0.05 and FC < -1.2) found in each biological triplicate from either the wild-type or mutant transcriptomes. Gene expression fold-
changes to respective controls (log2 ratios) are color-coded (red up-regulated and green down-regulated). Panel B: Representative GO categories enriched
for the down-regulated genes found in the mutant; Panel C: representative GO categories enriched for the down-regulated genes found in the wild-type
transcriptome. Length of bar corresponds to degree of significance (longer bars = greater significance), p-values determined by Benjamini-Hochberg
procedure.
doi:10.1371/journal.pone.0148726.g008
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It is possible that the changes in inflammatory gene expression could be accounted for by
the peripheral glia or by the immune cells recruited to the sites of nerve injury. To determine if
macrophages and/or microglia are contributing to the observed up-regulated inflammatory
gene expression, we utilized the pantherj4e (csfr1a-/-)mutant line. In this line, colonization of
the head by macrophages and microglia is delayed until after 4 dpf [53]. Previously, we showed
that in these mutants macrophages were not recruited to the areas of MET-induced neuronal
damage [29]. When transcription levels for a number of the inflammation-related DEGs were
assayed by qPCR using cDNA from 5 hr MET-treated 3.2:NTR;pantherj4e larvae versus
untreated larvae, elevated expression levels similar to those seen for larvae in a wild-type back-
ground were found (Fig 9). This finding, together with the results from the foxd3 mutant work,
strongly suggests that it is the peripheral glia that are the source of the increased transcription
seen for these genes after 5 hrs of MET-induced neuronal damage.
These findings, together with those obtained using in vivo imaging [29], provide support for
the proposition that non-myelinating glia are undergoing a conversion from a supporting,
ensheathing cell phenotype to one involving active phagocytosis and recruitment of macro-
phages. A similar process has been more fully investigated in myelinated nerve injury. Upon
nerve injury, myelinating Schwann cells stop producing myelin [54] and begin phagocytosing
debris via a novel form of autophagy [16]. Schwann cells then exhibit increased expression of
markers for immature Schwann cells [52] in a process that has been termed both dedifferentia-
tion and activation, resulting in a ‘repair’ Schwann cell that is critical for axonal regeneration
[14]. This phenotypic plasticity is driven by activation of signaling pathways involving p38/
MAPK [55, 56] and ERK [57, 58]. Activation of those pathways leads to a rapid increase in the
levels of the transcription factor c-jun, a known negative modulator of myelination [59]. In a
subsequent study using c-junmutant mice, a large number of genes normally up-regulated in
injured nerves (including several involved in neuronal survival and regeneration) were not acti-
vated, there was increased death of sensory neurons in response to nerve crush, myelin
Fig 9. qPCR results for gene expression in wild-type and panthermutants. Bar graph showing qPCR
determined log fold change (log FC) in expression of cebpb, il6st, junbb, and tnfrsf1a in wild type larvae
(blue) and panther (csfr1aj4e1) mutant larvae (red). Data represent means ± S.E.M. of at least 3 experiments.
Differences in mean values between conditions for each gene were not statistically significant.
doi:10.1371/journal.pone.0148726.g009
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clearance was delayed, axon regeneration was impaired and functional nerve recovery failed
[15]. These findings led the authors to propose that c-jun acts as a ‘master regulator’ of
Schwann cell reprogramming in response to axonal injury. We did not observe any changes in
c-jun transcription in our study, which suggests the possibility that myelinating and non-myeli-
nating glia might respond to axonal damage differently.
This idea is supported by several studies investigating the molecular responses of non-mye-
linating glial to nerve injury. Cheepudomwit et al. [60] reported that levels of RNA encoding the
cytokines MCP, IL-2, IL-6 and IL-10, IL-1ß and LIF RNA were increased in the sciatic nerve
when it was transected (affecting both unmyelinated and myelinated nerves axons), but that the
increases in sciatic IL-1ß and LIF RNAs were not seen when unmyelinated axons were selectively
damaged using capsaicin injections. Additional indirect support comes from studies demonstrat-
ing differences in proliferative responses of non-myelinating versus myelinating glia in motor
nerve injury and in growth factor expression after nerve root denervation/grafting [61–63].
While c-jun expression was unaltered in our model, a number of other transcription factors
(TF) did show changes in the wild-type at both 2 hrs (cbx7a, ddx26b, dedd1, dtl, e2f2, e2f3,
egln3, egr4, fboxo15, fosl1a, hbp1, hif1al, ier2, klf9, klf13, klf16, klf17, nr0b2a, nr0b2b, nr1i2 and
rxrab) and at 5 hrs (agf2, bzw1b, cbx7a, cebpb, cebpd, ddx26b, egln3, fosl1a, hif1al, hig1, junbb,
klf9, klf13, nr0b2b and nr1i2) of MET-treatment. These most likely underrepresent the total
number of TF that are affected, as it is highly likely that additional TF are present among the
numerous uncharacterized genes present in each of the DEGs pools. The incomplete overlap
between these two groups of TF most likely explains the differences in the panels of DEG seen
at the two timepoints.
Involvement of IL6 and TNF signaling pathways in responses to axonal injury/degeneration
is not unexpected, as previous studies have implicated these pathways as being activated in vari-
ous models of peripheral nerve injury [60, 64–66]. However, as both sensory neurons and periph-
eral glia express the genes for multiple cytokines, chemokines and their receptors, including IL-6
and its co-receptor proteins il6st (gp130) and il6r [64, 67] it remains to be determined if the sig-
naling is from neuron to glia, glia to glia or glia to neuron, or a combination thereof.
This is the first transcriptome study of metronidazole-induced neuronal death in zebrafish
and the response of non-myelinating glia to sensory neuron degeneration. As the appropriate
tools become available, future investigation into specific genes and cellular processes in selected
subpopulations of cranial cells will provide a deeper understanding of how the non-myelinat-
ing glial response to axonal and soma degeneration leads to activation of the pro-inflammatory
pathways underlying responses to nerve injury.
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